10 months ago
CRL
AnalystsRoss MukenRoss Muken's Stock Forecasts
AnalystsRoss Muken
Analyst Ranking
Top 25%
#1333 out of 5327 analysts
Average Return
+9.95%
Win Rate
75%21 out of 28
Risk vs Reward
Poor
Good
Ross Muken's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rite Aid CorpRADCQ | +61.83% | $40.60 | $15.50 | 2018-01-05 - 2019-01-04 | Sell |
Charles River Laboratories International IncCRL | +47.71% | $148.74 | $219.70 | 2025-08-08 - 2026-07-20 | Buy |
Rite Aid CorpRADCQ | +41.36% | $59.00 | $34.60 | 2017-06-30 - 2018-06-29 | Sell |
Charles River Laboratories International IncCRL | +40.88% | $158.97 | $223.96 | 2025-07-09 - 2026-07-08 | Buy |
Charles River Laboratories International IncCRL | +38.01% | $79.32 | $109.47 | 2017-01-04 - 2018-01-04 | Strong Buy |
Ross Muken Analyst Color
Get additional color on Ross Muken's coverage of popular stocks
Ross Muken's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Icon PLCICLR | 7 | Buy | $180.00 | +8.32% | Maintains | a month ago |
Charles River Laboratories International IncCRL | 12 | Buy | $220.00 | +0.14% | Maintains | 2 months ago |
Henry Schein IncHSIC | 7 | Hold | $70.00 | -18.79% | Maintains | a year ago |
Patterson Companies IncPDCO | 4 | Hold | $22.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 10 | Hold | $130.00 | N/A | Maintains | 2 years ago |
Rite Aid CorpRADCQ | 2 | Sell | $30.00 | N/A | Initiates Coverage On | 9 years ago |
Cardinal Health IncCAH | 1 | Hold | $67.00 | N/A | Initiates Coverage On | 9 years ago |
Illumina IncILMN | 2 | Buy | $250.00 | N/A | Initiates Coverage On | 9 years ago |
Qiagen NvQGEN | 1 | Buy | $36.05 | N/A | Initiates Coverage On | 9 years ago |
Thermo Fisher Scientific IncTMO | 1 | Buy | $220.00 | N/A | Initiates Coverage On | 9 years ago |
Parexel International CorpPRXL | 2 | Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.